Effects of AQP4 and KCNJ10 Gene Polymorphisms on Drug Resistance and Seizure Susceptibility in Chinese Han Patients with Focal Epilepsy

References

• Yuen A, Keezer MR, Sander JW. Epilepsy is a neurological and a systemic disorder. Epilepsy Behav. 2018;78:57–61. doi:10.1016/j.yebeh.2017.10.01029175221
   PubMed Web of Science ®Google Scholar
• Xiong J, Mao D, Liu L. Research progress on the role of ABC transporters in the drug resistance mechanism of intractable epilepsy. Biomed Res Int. 2015;2015:1–10.
   Web of Science ®Google Scholar
• Peng J, Pang N, Wang Y, et al. Next-generation sequencing improves treatment efficacy and reduces hospitalization in children with drug-resistant epilepsy. CNS Neurosci Ther. 2019;25(1):14–20. doi:10.1111/cns.2019.25.issue-129933521
   PubMed Web of Science ®Google Scholar
• Liu Z, Yin X, Liu L, et al. Association of KEAP1 and NFE2L2 polymorphisms with temporal lobe epilepsy and drug resistant epilepsy. Gene. 2015;571(2):231–236. doi:10.1016/j.gene.2015.06.05526149655
   PubMed Web of Science ®Google Scholar
• Siddiqui A, Kerb R, Weale ME, et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med. 2003;348(15):1442–1448. doi:10.1056/NEJMoa02198612686700
   PubMed Web of Science ®Google Scholar
• Ufer M, von Stulpnagel C, Muhle H, et al. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy. Pharmacogenet Genomics. 2011;21(10):624–630. doi:10.1097/FPC.0b013e328349813121799461
   PubMed Web of Science ®Google Scholar
• Qu J, Zhou BT, Yin JY, et al. ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients. CNS Neurosci Ther. 2012;18(8):647–651. doi:10.1111/j.1755-5949.2012.00336.x22630058
   PubMed Web of Science ®Google Scholar
• Qian L, Fang S, Yan Y, Zeng S, Xu Z, Gong Z. The ABCC2 c.-24C>T polymorphism increases the risk of resistance to antiepileptic drugs: a meta-analysis. J Clin Neurosci. 2017;37:6–14. doi:10.1016/j.jocn.2016.10.01427816260
   PubMed Web of Science ®Google Scholar
• Binder DK, Nagelhus EA, Ottersen OP. Aquaporin-4 and epilepsy. Glia. 2012;60(8):1203–1214. doi:10.1002/glia.2231722378467
   PubMed Web of Science ®Google Scholar
• Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA. Glia and epilepsy: excitability and inflammation. Trends Neurosci. 2013;36(3):174–184. doi:10.1016/j.tins.2012.11.00823298414
   PubMed Web of Science ®Google Scholar
• Kinboshi M, Shimizu S, Mashimo T, et al. Down-regulation of astrocytic Kir4.1 channels during the audiogenic epileptogenesis in Leucine-Rich Glioma-Inactivated 1 (Lgi1) mutant rats. Int J Mol Sci. 2019;20(5):1013. doi:10.3390/ijms20051013
   Web of Science ®Google Scholar
• Das A, Wallace GT, Holmes C, et al. Hippocampal tissue of patients with refractory temporal lobe epilepsy is associated with astrocyte activation, inflammation, and altered expression of channels and receptors. Neuroscience. 2012;220:237–246. doi:10.1016/j.neuroscience.2012.06.00222698689
   PubMed Web of Science ®Google Scholar
• Heuser K, Eid T, Lauritzen F, et al. Loss of perivascular Kir4.1 potassium channels in the sclerotic hippocampus of patients with mesial temporal lobe epilepsy. J Neuropathol Exp Neurol. 2012;71(9):814–825. doi:10.1097/NEN.0b013e318267b5af22878665
   PubMed Web of Science ®Google Scholar
• Heuser K, Nagelhus EA, Tauboll E, et al. Variants of the genes encoding AQP4 and Kir4.1 are associated with subgroups of patients with temporal lobe epilepsy. Epilepsy Res. 2010;88(1):55–64. doi:10.1016/j.eplepsyres.2009.09.02319864112
   PubMed Web of Science ®Google Scholar
• Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58(4):522–530. doi:10.1111/epi.1367028276060
   PubMed Web of Science ®Google Scholar
• Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE commission on therapeutic strategies. Epilepsia. 2010;51(6):1069–1077. doi:10.1111/j.1528-1167.2009.02397.x19889013
   PubMed Web of Science ®Google Scholar
• Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ. 1995;310(6973):170. doi:10.1136/bmj.310.6973.1707833759
   PubMed Web of Science ®Google Scholar
• Saadoun S, Papadopoulos MC, Watanabe H, Yan D, Manley GT, Verkman AS. Involvement of aquaporin-4 in astroglial cell migration and glial scar formation. J Cell Sci. 2005;118(Pt 24):5691–5698. doi:10.1242/jcs.0268016303850
   PubMed Web of Science ®Google Scholar
• Pecorelli A, Natrella F, Belmonte G, et al. NADPH oxidase activation and 4-hydroxy-2-nonenal/aquaporin-4 adducts as possible new players in oxidative neuronal damage presents in drug-resistant epilepsy. Biochim Biophys Acta. 2015;1852(3):507–519. doi:10.1016/j.bbadis.2014.11.01625460197
   PubMed Web of Science ®Google Scholar
• Verkhratsky A, Rodriguez JJ, Parpura V. Astroglia in neurological diseases. Future Neurol. 2013;8(2):149–158. doi:10.2217/fnl.12.9023658503
   PubMedGoogle Scholar
• Hubbard JA, Szu JI, Binder DK. The role of aquaporin-4 in synaptic plasticity, memory and disease. Brain Res Bull. 2018;136:118–129. doi:10.1016/j.brainresbull.2017.02.01128274814
   PubMed Web of Science ®Google Scholar
• Bebek N, Ozdemir O, Sayitoglu M, et al. Expression analysis and clinical correlation of aquaporin 1 and 4 genes in human hippocampal sclerosis. J Clin Neurosci. 2013;20(11):1564–1570. doi:10.1016/j.jocn.2012.12.02323928039
   PubMed Web of Science ®Google Scholar
• Hubbard JA, Szu JI, Yonan JM, Binder DK. Regulation of astrocyte glutamate transporter-1 (GLT1) and aquaporin-4 (AQP4) expression in a model of epilepsy. Exp Neurol. 2016;283(Pt A):85–96. doi:10.1016/j.expneurol.2016.05.00327155358
   PubMed Web of Science ®Google Scholar
• Short B, Kozek L, Harmsen H, et al. Cerebral aquaporin-4 expression is independent of seizures in tuberous sclerosis complex. Neurobiol Dis. 2019;129:93–101. doi:10.1016/j.nbd.2019.05.00331078684
   PubMed Web of Science ®Google Scholar
• Nagelhus EA, Mathiisen TM, Ottersen OP. Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with KIR4.1. Neuroscience. 2004;129(4):905–913. doi:10.1016/j.neuroscience.2004.08.05315561407
   PubMed Web of Science ®Google Scholar
• Djukic B, Casper KB, Philpot BD, Chin LS, McCarthy KD. Conditional knock-out of Kir4.1 leads to glial membrane depolarization, inhibition of potassium and glutamate uptake, and enhanced short-term synaptic potentiation. J Neurosci. 2007;27(42):11354–11365. doi:10.1523/JNEUROSCI.0723-07.200717942730
   PubMed Web of Science ®Google Scholar
• Ohno Y, Kinboshi M, Shimizu S. Inwardly rectifying potassium channel Kir4.1 as a novel modulator of BDNF expression in astrocytes. Int J Mol Sci. 2018;19(11):3313. doi:10.3390/ijms19113313
   Web of Science ®Google Scholar
• Lenzen KP, Heils A, Lorenz S, et al. Supportive evidence for an allelic association of the human KCNJ10 potassium channel gene with idiopathic generalized epilepsy. Epilepsy Res. 2005;63(2–3):113–118. doi:10.1016/j.eplepsyres.2005.01.00215725393
   PubMed Web of Science ®Google Scholar
• Dai AI, Akcali A, Koska S, Oztuzcu S, Cengiz B, Demiryurek AT. Contribution of KCNJ10 gene polymorphisms in childhood epilepsy. J Child Neurol. 2015;30(3):296–300. doi:10.1177/088307381453956025008907
   PubMed Web of Science ®Google Scholar
• Guo Y, Yan KP, Qu Q, et al. Common variants of KCNJ10 are associated with susceptibility and anti-epileptic drug resistance in Chinese genetic generalized epilepsies. PLoS ONE. 2015;10(4):e124896.
   Web of Science ®Google Scholar
• Mathieu O, Bouche N. Interplay between chromatin and RNA processing. Curr Opin Plant Biol. 2014;18:60–65. doi:10.1016/j.pbi.2014.02.00624631845
   PubMed Web of Science ®Google Scholar